Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis
about
Setup for human sera MALDI profiling: the case of rhEPO treatment.Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis.Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virus.Serum peptides, represented by complement 3f des-arginine, are useful for prediction of the response to pegylated interferon-α plus ribavirin in patients with chronic hepatitis C.
P2860
Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of treatment ef ...... by ProteinChip serum analysis
@ast
Identification of treatment ef ...... by ProteinChip serum analysis
@en
type
label
Identification of treatment ef ...... by ProteinChip serum analysis
@ast
Identification of treatment ef ...... by ProteinChip serum analysis
@en
prefLabel
Identification of treatment ef ...... by ProteinChip serum analysis
@ast
Identification of treatment ef ...... by ProteinChip serum analysis
@en
P2093
P2860
P1433
P1476
Identification of treatment ef ...... by ProteinChip serum analysis
@en
P2093
Mamoru Nakanishi
Masahiko Kaito
Naoki Fujita
Takafumi Ichida
Toshikazu Yoshikawa
Yoshiyuki Takei
Yuuji Naito
P2860
P2888
P356
10.2119/MOLMED.2010.00124
P407
P577
2010-10-05T00:00:00Z
P5875
P6179
1068965297